In fact, the authors found that VitC treatment of human and mouse cancer cell lines induced vitcylation of a specific lysine residue (K298) in STAT1 associated with enhanced phosphorylation at tyrosine 701 and increased STAT1 activity. This evidence concerns the gene STAT1 and cancer.